Company: SMNR
Filing Date: 2025-07-23
Form Type: S-4/A
Source: 0001193125-25-163401
Chunk: 627

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-23
Form: S-4/A
Chunk 627
---
| • |     | reviewing and discussing with appropriate executive officers of New Semnur compensation-related proposals to be considered at New Semnur’s annual meeting, including the Say on Pay Vote and the frequency of the Say on Pay Vote, and the results of any stockholder advisory votes and, based on such discussions, providing recommendations to the New Semnur Board; and |

| • |     | reviewing and discussing with management New Semnur’s Compensation Discussion and Analysis, and recommending to the New Semnur Board that the Compensation Discussion and Analysis be approved for inclusion in New Semnur’s annual reports on Form 10-K, registration statements, New Semnur’s annual meeting proxy statements and information statements. |

Under its charter, the compensation committee may form, and delegate authority to, subcommittees as appropriate. The compensation committee will review, discuss and assess its own performance and composition at least annually. The compensation committee will also periodically review and assess the adequacy of its charter, including its role and responsibilities as outlined in its charter, and recommend any proposed changes to the New Semnur Board for its consideration and approval. The composition and functioning of the compensation committee will comply with all applicable requirements of the Sarbanes-Oxley Act and all applicable SEC rules and Nasdaq Listing Rules. New Semnur intends to comply with future requirements to the extent they become applicable to New Semnur. 384

Nominating and Corporate Governance Committee New Semnur’s nominating and corporate governance committee will consist of Dorman Followwill and Yue Alexander Wu, Ph.D., with Dorman Followwill serving as the chairperson of the committee. Dorman Followwill and Yue Alexander Wu, Ph.D. will each satisfy the independence requirements under the Nasdaq Listing Rules. The responsibilities of the nominating and corporate governance committee are included in its written charter. The nominating and corporate governance committee will act on behalf of the New Semnur Board to fulfill the New Semnur Board’s responsibilities in overseeing all aspects of the company’s nominating and corporate governance functions. The responsibilities of the nominating and corporate governance committee will include, among others:

| • |     | making recommendations to the New Semnur Board regarding corporate governance issues; |

| • |     | identifying, reviewing and evaluating candidates to serve as directors (consistent with criteria approved by the New Semnur Board); |

| • |     | determining the minimum qualifications for service on the New Semnur Board; |

| • |     | reviewing